Qbrelis Solution
Product Images NDC 52652-3001

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Qbrelis (NDC 52652-3001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure of lisinopril, the active ingredient in Qbrelis 1 mg/mL oral solution. The diagram shows the molecular arrangement including amine, carboxyl, and other functional groups, along with water of crystallization (2H2O).*

FDA Label Image

Principal Display Panel (Bottle Label)

Label for Qbrelis (lisinopril) oral solution, 1 mg/mL, a human prescription drug by Azurity Pharmaceuticals, Inc. The label shows a 150 mL bottle size and includes storage instructions, dosage remarks, and warnings to keep out of children's reach. The label features the Azurity Pharmaceuticals logo and NDC 52652-3001-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.